A fusion fragment from Flt-1 and KDR,acted as VEGF decoy receptor and exhibited anti-tumor function |
| |
Authors: | Zhuang-Lin Li Xue-Jing Yao Wei-Feng Liu Guan-Jun Chen |
| |
Institution: | (1) State Key Laboratory of Microbial Technology, Shandong University, Jinan, 250100, China;(2) Yantai Rongchang Bioengineering Co., Ltd., Yantai, 264006, China; |
| |
Abstract: | Angiogenesis is important in tumor development. Vascular endothelial growth factor (VEGF) is involved in this process. In
this report, we constructed a recombinant protein (called FK) by fusing the second immunoglobulin-like (Ig-like) domain of
a human fms-like tyrosine kinase (Flt-1) with the third Ig-like domain of human kinase insert domain-containing receptor (KDR). FK bound
to VEGF165 in a dose-dependent manner with a disocciation constant (Kd) of 2.7 pM. In addition, FK specifically inhibited the proliferation
of human microvascular endothelial cell (HMEC) and human umbilical vein endothelial Cell (HUVEC) stimulated by VEGF165. Subsequent studies also demonstrate that FK efficaciously suppresses growth of a variety of tumors, which could make FK
a potential drug candidate in anti-tumor therapy. |
| |
Keywords: | |
本文献已被 SpringerLink 等数据库收录! |
|